- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03926312
Smart Device-based Cardiac Rehabilitation After Myocardial Intervention (SmartRehab)
October 5, 2023 updated by: Peter Wohlfahrt, Charles University, Czech Republic
The aim of this study is to evaluate the influence of cardiac rehabilitation based on smart band use and telemonitoring on functional capacity change and risk factors control among patients hospitalized for acute myocardial infarction.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
64
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Peter Wohlfahrt, MD, PhD
- Phone Number: 00420739777244
- Email: wohlfp@gmail.com
Study Locations
-
-
CZEC
-
Prague, CZEC, Czechia, 14021
- Institute for Clinical and Experimental Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Signed informed consent with the study
- Men and women >18 years of age
- Patients ≥1 and ≤6 months after type I myocardial infarction
- Physical inactivity before MI defined as the absence of moderate to vigorous exercise for at least 30 minutes 5 or more days a week
Exclusion Criteria:
- Heart failure NYHA IIIB-IV
- Planned coronary revascularization
- Planned major surgery within the next 12 months
- Inability to walk for any reason
- Comorbidities that would preclude adherence to the rehabilitation program (e.g. arthrosis, active malignancy, major depression or other significant psychiatric disorder, cognitive impairment) - at the discretion of the physician
- Life expectancy less than 12 months
- Pregnancy
- Inability to operate the smart-watch
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Smart device-based rehabilitation
One month after myocardial infarction, patients will receive a smart band and a cellphone in order to transmit data on physical activity to electronic health record.
A study nurse will periodically check compliance with recommended physical activity and intervene in the case of non-compliance.
|
A smart device coupled with remote monitoring will be used to increase physical activity of patients after myocardial infarction with a history of low physical activity.
|
No Intervention: Control group
Patients will receive a guideline directed recommendation to increase physical activity to 30 minutes of moderate physical activity a week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional capacity change
Time Frame: 3 months
|
6-minute walk test distance and maximal oxygen consumption (VO2 max) change after 3 months of the intervention
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Waist circumference
Time Frame: 3 months
|
Waist circumference change after 3 months of the intervention
|
3 months
|
Body fat percentage
Time Frame: 3 months
|
Body fat percentage change after 3 months of the intervention
|
3 months
|
Smoking cessation
Time Frame: 3 months
|
Smoking cessation after 3 months of the intervention
|
3 months
|
Lipid levels
Time Frame: 3 months
|
Lipid levels change after 3 months of the intervention
|
3 months
|
Blood pressure
Time Frame: 3 months
|
Blood pressure change after 3 months of the intervention
|
3 months
|
Glycated hemoglobin
Time Frame: 3 months
|
Glycated hemoglobin change after 3 months of the intervention
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Peter Wohlfahrt, MD, PhD, Institute for Clinical and Experimental Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 19, 2019
Primary Completion (Actual)
October 5, 2023
Study Completion (Actual)
October 5, 2023
Study Registration Dates
First Submitted
April 21, 2019
First Submitted That Met QC Criteria
April 23, 2019
First Posted (Actual)
April 24, 2019
Study Record Updates
Last Update Posted (Estimated)
October 9, 2023
Last Update Submitted That Met QC Criteria
October 5, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SmartRehab
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myocardial Infarction
-
Azienda ULSS 5 PolesanaUniversity of PadovaUnknownMyocardial Infarction, Acute | ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Italy
-
University Medical Centre LjubljanaCompletedCardiac Arrest | Postresuscitation Syndrome | Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)Slovenia
-
Fundacio Privada Mon Clinic BarcelonaMiracor Medical SANot yet recruiting
-
Stiftung Institut fuer HerzinfarktforschungGlaxoSmithKline; University Hospital Muenster; Klinikum NürnbergCompletedMyocardial Infarction | ST-Elevation Myocardial Infarction | Non-ST-Elevation Myocardial InfarctionGermany
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Boston Scientific CorporationActive, not recruitingST Elevation Myocardial Infarction | Non ST Elevation Myocardial InfarctionCanada
-
Bispebjerg HospitalOdense University Hospital; Zealand University Hospital; Hvidovre University... and other collaboratorsRecruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Denmark
-
Barts & The London NHS TrustUniversity College, London; Queen Mary University of LondonCompletedAcute Myocardial InfarctionSwitzerland, Denmark, United Kingdom
-
University of LeedsUniversity College, LondonCompletedST-elevation Myocardial Infarction | Non ST-elevation Myocardial Infarction
-
Karolinska InstitutetUppsala University; The Swedish Research CouncilActive, not recruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial InfarctionSweden
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; University Hospital of North... and other collaboratorsActive, not recruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial InfarctionNorway
Clinical Trials on Smart device-based cardiac rehabilitation
-
Federico II UniversityCompletedAcute Myocardial InfarctionItaly
-
Universidade Estadual Paulista Júlio de Mesquita...CompletedCardiovascular Diseases | Cardiac Risk FactorsBrazil
-
Mayo ClinicJohns Hopkins University; University of California, Irvine; University of Mississippi...Not yet recruitingCardiovascular Diseases | Telemedicine | Cardiac EventUnited States
-
Universidade do PortoCentro Hospitalar de Vila Nova de Gaia/Espinho; Research Center in Physical...CompletedCoronary Artery DiseasePortugal
-
University of ChesterUniversity Hospitals of Derby and Burton NHS Foundation TrustCompletedCardiovascular DiseasesUnited Kingdom
-
Maxima Medical CenterCompletedMyocardial Infarction | Acute Coronary SyndromeNetherlands
-
Université de SherbrookeActive, not recruiting
-
Universidade Estadual Paulista Júlio de Mesquita...RecruitingCardiovascular Diseases | Cardiovascular Risk FactorBrazil
-
Washington University School of MedicineThe Foundation for Barnes-Jewish HospitalRecruitingSarcoma | Breast Cancer | Hodgkin Disease | Hodgkin Lymphoma | Esophageal Cancer | Thymoma | Lung Cancer | Thoracic Cancer | Non-hodgkin LymphomaUnited States
-
Taichung Veterans General HospitalCompletedHeart Failure With or Without CRT-P/D